EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes

Zhengbao Zhu iD, Yiming Jia iD, Fu-Rong Li, Yang Li, Li-Hua Chen, Huan-Huan Yang, Daoxia Guo, Lulu Sun, Mengyao Shi, Tao Wang iD, Thomas E Rohan, Qibin Qi und 3 weitere

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad163 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Zhengbao Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzho…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Mendelian Randomization Analysis, Crohn Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Postdoctoral Science Foundation, Development of Jiangsu Higher Education Institutions, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) was associated with elevated risk of cardiometabolic diseases in observational studies. We aimed to evaluate the observational and genetic associations of Crohn’s disease (CD) and ulcerative colitis (UC) with multiple cardiometabolic outcomes.

Methods

Our phenotypic and genetic association analyses included more than 400 000 participants who were free of major cardiovascular disease and diabetes at recruitment (2006-2010) and were followed up until December 2019 based on the UK Biobank. For the Mendelian randomization (MR) analyses, 415 and 273 single nucleotide polymorphisms associated with CD and UC, respectively, were selected as genetic instruments. Summary-level data on individual cardiometabolic outcomes were obtained from 4 different genome-wide association studies with a total of 2 248 842 participants.

Results

In the multivariable-adjusted observational analyses, CD was associated with higher risks of heart failure (hazard ratio [HR], 1.72; 95% confidence interval, 1.22-2.42) and type 2 diabetes (HR, 2.11; 95% confidence interval, 1.67-2.67) but not with myocardial infarction or ischemic stroke. UC was related to increased risks of all the assessed cardiometabolic diseases (HRs ranged from 1.29 for myocardial infarction to 1.76 for type 2 diabetes). Conversely, neither the genetic risk score for CD nor that for UC was associated with higher risk of developing cardiometabolic diseases. In 2-sample MR analyses, genetically determined CD and UC were not associated with any of the assessed cardiometabolic diseases (all P values >.05).

Conclusions

Despite confirming the observational associations, our study does not support a causal association between IBD and elevated risk of cardiometabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesMendelian Randomization AnalysisCrohn DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideHumansFemaleMaleMiddle AgedAdultColitis, UlcerativeRisk FactorsAgedUnited KingdomInflammatory Bowel DiseasesGenetic Predisposition to Disease

Stichwörter der Autor:innen

Crohn’s diseasecardiovascular diseasecausalitytype 2 diabetesulcerative colitis

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, Suzhou, China.
  • Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
  • School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
  • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, China.
  • Vanke School of Public Health, Tsinghua University, Beijing, China.

ORCID-Profile: Zhengbao Zhu, Yiming Jia, Tao Wang

Förderung

  • National Natural Science Foundation of China
  • Chinese Postdoctoral Science Foundation
  • Development of Jiangsu Higher Education Institutions, China

Zitieren

APA

Zhu, Z., Jia, Y., Li, F. R., Li, Y., Chen, L. H., Yang, H. H., Guo, D., Sun, L., Shi, M., Wang, T., Rohan, T. E., Qi, Q., Qin, L. Q., Zhang, Y., & Chen, G. C. (2024). Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad163

Vancouver

Zhu Z, Jia Y, Li FR, Li Y, Chen LH, Yang HH, et al. Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad163

BibTeX
@article{Zhu2024,
  author = {Zhu, Zhengbao and Jia, Yiming and Li, Fu-Rong and Li, Yang and Chen, Li-Hua and Yang, Huan-Huan and Guo, Daoxia and Sun, Lulu and Shi, Mengyao and Wang, Tao and Rohan, Thomas E and Qi, Qibin and Qin, Li-Qiang and Zhang, Yonghong and Chen, Guo-Chong},
  title = {Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad163}
}
Kostenlos starten →